Strides Pharma Science Ltd Q3 FY2025-2026 Results: Summary

Revenue
₹1,301.51Cr
Net Profits
₹202.11Cr
Net Profit Margins
15.53%
Highlights
Revenue:

Strides Pharma Science Ltd’s revenue jumped 12.18% since last year same period to ₹1,301.51Cr in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 4.29% jump in its revenue since last 3-months.

Net Profits:

Strides Pharma Science Ltd’s net profit jumped 129.8% since last year same period to ₹202.11Cr in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 58.48% jump in its net profits since last 3-months.

Net Profit Margins:

Strides Pharma Science Ltd’s net profit margin jumped 104.86% since last year same period to 15.53% in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 51.96% jumped in its net profit margins since last 3-months.

FAQs

What was the revenue for Strides Pharma Science Ltd in Q3 results 2025?

The revenue for Strides Pharma Science Ltd in the Q3 results 2025 was ₹1,301.51Cr.

What was the net profit for Strides Pharma Science Ltd in Q3 results 2025?

The net profit for Strides Pharma Science Ltd in the Q3 results 2025 was ₹202.11Cr.

What was the net profit margin for Strides Pharma Science Ltd in Q3 results 2025?

The net profit margin for Strides Pharma Science Ltd in the Q3 results 2025 was 15.53%.

What was the revenue for Strides Pharma Science Ltd in Q3 results 2024?

The revenue for Strides Pharma Science Ltd in the Q3 results 2024 was ₹1,160.24Cr.

What was the net profit for Strides Pharma Science Ltd in Q3 results 2024?

The net profit for Strides Pharma Science Ltd in the Q3 results 2024 was ₹87.95Cr.

What was the net profit margin for Strides Pharma Science Ltd in Q3 results 2024?

The net profit margin for Strides Pharma Science Ltd in the Q3 results 2024 was 7.58%.